This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Brightness alteration
Brightness alteration can be described as a distortion or change in the levels of perceived brightness comprising one's vision. This usually results in one's vision becoming darker and gloomier, but could also potentially result in it becoming whiter and brighter depending on the person's environment and substances consumed.
Brightness alteration is most commonly induced under the influence of moderate dosages of hallucinogenic compounds, such as psychedelics, dissociatives and cannabinoids. However, it can also occur less commonly under the influence of certain stimulants such as MDMA or amphetamine.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 2-FEA
- 2-FMA
- 25B-NBOH
- 25C-NBOH
- 25I-NBOH
- 25I-NBOMe
- 3-FPM
- 3C-E
- 3C-P
- 4-AcO-DET
- 4-AcO-MiPT
- 4-HO-DPT
- 4-HO-DiPT
- 4-HO-EPT
- 4-HO-MPT
- 4-HO-MiPT
- 5-MeO-DiPT
- A-PHP
- A-PVP
- Allylescaline
- Amphetamine
- Blue Lotus
- Cannabis
- Cyclazodone
- DET
- DOB
- DOC
- DOI
- DOM
- Datura
- Desoxypipradrol
- Diphenhydramine
- LSM-775
- Lisdexamfetamine
- MET
- MPT
- Memantine
- Methallylescaline
- MiPT
- PARGY-LAD
- PRO-LAD
- Propylhexedrine
- Proscaline
- Βk-2C-B
See also
- Responsible use
- Hallucinogens
- Deliriants
- Subjective effects index
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects